| Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients (NCT01308944) | Washington University School of Medicine | 2010-08-01 |
| Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM (NCT01114282) | Stanford University | 2010-08-01 |
| Monitoring Exhaled Propofol to Individualize General Anesthesia (NCT01191021) | University of California, San Francisco | 2010-08-01 |
| Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823 (NCT01189175) | Boehringer Ingelheim | 2010-08-01 |
| Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors (NCT01151670) | Wake Forest University Health Sciences | 2010-08-01 |
| The Physical and Psychological Benefits of Yoga and Breast Cancer (NCT01230671) | Dr. Sarkis Meterissian | 2010-08-01 |
| First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine (NCT01188512) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-08-01 |
| Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males (NCT01184976) | GeneOne Life Science, Inc. | 2010-08-01 |
| A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers. (NCT01160003) | GlaxoSmithKline | 2010-07-29 |
| A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors (NCT01176500) | National Cancer Institute (NCI) | 2010-07-28 |
| Single Dose Partial Breast Radiotherapy (NCT00944528) | Duke University | 2010-07-28 |
| A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT01182883) | National Cancer Institute (NCI) | 2010-07-28 |
| Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors (NCT01138033) | GlaxoSmithKline | 2010-07-27 |
| A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors (NCT01143753) | Hoffmann-La Roche | 2010-07-27 |
| Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) (NCT01171898) | Aragon Pharmaceuticals, Inc. | 2010-07-26 |
| Japanese Phase I of GSK1605786 (NCT01611805) | GlaxoSmithKline | 2010-07-22 |
| Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery (NCT01159964) | GlaxoSmithKline | 2010-07-20 |
| Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma (NCT01177397) | Celgene | 2010-07-20 |
| Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) (NCT01381536) | GlaxoSmithKline | 2010-07-20 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults (NCT01160172) | GlaxoSmithKline | 2010-07-19 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) (NCT01206517) | Organon and Co | 2010-07-18 |
| Bioequivalence Study of Nimesulide 100 mg Tablets (NCT01745614) | GlaxoSmithKline | 2010-07-18 |
| Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies (NCT01165658) | M.D. Anderson Cancer Center | 2010-07-16 |
| QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA (NCT01147965) | NantCell, Inc. | 2010-07-16 |
| A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions (NCT01046162) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-15 |
| First-in-Human Study of PF-04958242 in Healthy Volunteers (NCT01159483) | Biogen | 2010-07-15 |
| Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. (NCT01165762) | Everett Meyer | 2010-07-14 |
| A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects (NCT01128855) | GlaxoSmithKline | 2010-07-12 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis (NCT01160861) | Genentech, Inc. | 2010-07-11 |
| Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer (NCT01163084) | National Cancer Institute (NCI) | 2010-07-09 |
| Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects (NCT06159452) | Sanofi | 2010-07-09 |
| Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer (NCT01175733) | Amsterdam UMC, location VUmc | 2010-07-08 |
| Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma (NCT01089101) | National Cancer Institute (NCI) | 2010-07-07 |
| Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer (NCT01149343) | GlaxoSmithKline | 2010-07-02 |
| AC6 Gene Transfer for CHF (NCT00787059) | Hammond, H. Kirk, M.D. | 2010-07-01 |
| PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM) (NCT01192308) | Radboud University Medical Center | 2010-07-01 |
| Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia (NCT01207869) | China Medical University Hospital | 2010-07-01 |
| Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers. (NCT01170637) | Boehringer Ingelheim | 2010-07-01 |
| Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer (NCT01173172) | Taipei Veterans General Hospital, Taiwan | 2010-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis (NCT01164904) | Amgen | 2010-07-01 |
| Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin (NCT01163851) | Pfizer | 2010-07-01 |
| Strength, Flexibility, And Balance Therapy After Stroke (NCT01109602) | VA Office of Research and Development | 2010-07-01 |
| Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA) (NCT01136278) | University Hospital, Basel, Switzerland | 2010-07-01 |
| A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma (NCT01156584) | Tocagen Inc. | 2010-07-01 |
| Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects (NCT01159626) | Pfizer | 2010-07-01 |
| Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention (NCT01282580) | Ohio State University Comprehensive Cancer Center | 2010-07-01 |
| Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial (NCT01124058) | University of Alberta | 2010-07-01 |
| Impact of Varying Doses of Amino Acids on Exercise, Muscular and Mental Performance (NCT01215396) | McMaster University | 2010-07-01 |
| Study of Chemo-Immunotherapy in Head and Neck Cancer Patients (NCT01149902) | University of Yamanashi | 2010-07-01 |
| A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma (NCT01101594) | Gilead Sciences | 2010-07-01 |
| Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers (NCT01176851) | Chiesi Farmaceutici S.p.A. | 2010-07-01 |
| Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders (NCT01524458) | Chinese University of Hong Kong | 2010-07-01 |
| VA106483 Dose Response in Females (NCT01171391) | Vantia Ltd | 2010-07-01 |
| Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7 (NCT00922259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Oral Mucosal Absorption Study of Bicalutamide New Formulation (NCT01416883) | AstraZeneca | 2010-07-01 |
| Study to Investigate Multiple Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects (NCT01171105) | AstraZeneca | 2010-07-01 |
| To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity (NCT01165736) | Pfizer | 2010-07-01 |
| Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer (NCT01167816) | University of Oklahoma | 2010-07-01 |
| A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC) (NCT01106352) | Bayer | 2010-07-01 |
| To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects (NCT01175564) | AstraZeneca | 2010-07-01 |
| Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer (NCT01116089) | Chiesi Farmaceutici S.p.A. | 2010-07-01 |
| Eletriptan Pharmacokinetics In Korean Males (NCT01139515) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy (NCT01170286) | DBV Technologies | 2010-07-01 |
| Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers (NCT01147055) | Pfizer | 2010-07-01 |
| Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome (NCT01165996) | Case Comprehensive Cancer Center | 2010-07-01 |
| A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response (NCT01258634) | University of Chicago | 2010-07-01 |
| Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors (NCT01096030) | Bayer | 2010-07-01 |
| Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis (NCT01169038) | Vanderbilt University | 2010-07-01 |
| Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder (NCT01168895) | Bayer | 2010-07-01 |
| Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients (NCT01334099) | University Health Network, Toronto | 2010-07-01 |
| Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers (NCT01165502) | CellMed AG, a subsidiary of BTG plc. | 2010-07-01 |
| A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors (NCT01183364) | Synta Pharmaceuticals Corp. | 2010-07-01 |
| Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin (NCT02137668) | Sacramento Pediatric Gastroenterology | 2010-07-01 |
| Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors (NCT01170897) | Halozyme Therapeutics | 2010-07-01 |
| A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL) (NCT01005979) | Emory University | 2010-07-01 |
| A Study of Balapiravir in Patients With Dengue Virus Infection (NCT01096576) | Hoffmann-La Roche | 2010-07-01 |
| Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy (NCT01221181) | Columbia University | 2010-07-01 |
| Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults (NCT01157897) | U.S. Army Medical Research and Development Command | 2010-07-01 |
| Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) (NCT01167166) | Traws Pharma, Inc. | 2010-07-01 |
| Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects (NCT01140412) | ViiV Healthcare | 2010-07-01 |
| AMES + Brain Stimulation (NCT01169181) | AMES Technology | 2010-07-01 |
| Effects of Sulforaphane on Normal Prostate Tissue (NCT00946309) | Fred Hutchinson Cancer Center | 2010-07-01 |
| Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma (NCT01045915) | Valerio Therapeutics | 2010-07-01 |
| A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma (NCT01164891) | Hoffmann-La Roche | 2010-07-01 |
| Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors (NCT01155713) | Novartis Pharmaceuticals | 2010-07-01 |
| A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets (NCT01153659) | Eisai Inc. | 2010-07-01 |
| Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor (NCT01175096) | Guangdong Provincial People's Hospital | 2010-07-01 |
| Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects (NCT01154114) | GlaxoSmithKline | 2010-07-01 |
| A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet (NCT01900587) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-07-01 |
| Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760) (NCT01159496) | Pfizer | 2010-07-01 |
| Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients (NCT01160614) | Purdue Pharma LP | 2010-07-01 |
| Effect of Salba & Flax on Postprandial Glycemia and Subjective Satiety (NCT02621307) | Unity Health Toronto | 2010-07-01 |
| Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer (NCT01163448) | Memorial Sloan Kettering Cancer Center | 2010-07-01 |
| Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury (NCT01162915) | TCA Cellular Therapy | 2010-07-01 |
| Bioequivalence Study Of Phenytoin Suspension Versus Epamin® In 34 Healthy Volunteers. (NCT01122940) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-07-01 |
| Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults (NCT01172054) | VaxInnate Corporation | 2010-07-01 |
| Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure (NCT01149538) | University of Minnesota | 2010-07-01 |
| Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma (NCT01177683) | Sherif Farag, MB, BS | 2010-07-01 |
| Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults (NCT00853255) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia (NCT01127009) | Case Comprehensive Cancer Center | 2010-07-01 |